How It Helps: By engaging dual pathways, Tirzepatide offers robust support for appetite control, insulin sensitivity, and metabolic rate regulation
Monthly Cost Comparison Brand-name Ozempic (semaglutide for diabetes): $969 per month without insurance Brand-name Wegovy (semaglutide for weight loss): $1,349 per month without insurance Compounded semaglutide through TrimRx: $199 per month Monthly savings with compounded semaglutide: Versus Ozempic: $770 savings (79% less expensive) Versus Wegovy: $1,150 savings (85% less expensive) 6-Month Treatment Comparison For people using semaglutide for 6 months: Brand-name Ozempic: $5,814 Brand-name Wegovy: $8,094 Compounded semaglutide: $1,194 Savings over 6 months: Versus Ozempic: $4,620 Versus Wegovy: $6,900 12-Month Treatment Comparison For a full year of treatment: Brand-name Ozempic: $11,628 Brand-name Wegovy: $16,188 Compounded semaglutide: $2,388 Savings over 12 months: Versus Ozempic: $9,240 Versus Wegovy: $13,800 18-Month Treatment Comparison Most people need at least 18 months to achieve significant weight loss and stabilization: Brand-name Ozempic: $17,442 Brand-name Wegovy: $24,282 Compounded semaglutide: $3,582 Savings over 18 months: Versus Ozempic: $13,860 Versus Wegovy: $20,700 Cost Per Pound Lost Analysis Clinical trials showed average total body weight loss of 14.9% with semaglutide
Among over 500 obese patients with OSAS, long-term tirzepatide treatment led to significant reductions in body weight, AHI, and oxygen desaturation index, with particularly pronounced benefits in patients with concurrent glucose and lipid metabolism abnormalities (52)
The Risks of Skipping an Ozempic Dose If youve ever been tempted to skip or delay a GLP-1 dose in advance of a special occasion, such as a vacation or large holiday meal, experts warn that one missed dose is not likely to have a big effect on your hunger or gastrointestinal fitness
At Klinic in Manassas, Virginia, we focus solely on branded, FDA-approved medications like Wegovy, ensuring superior quality control, consistency, and the reassurance of FDA oversight
